Mount Sinai Health System
Search
Placeholder image for Neil A Halpern

    Neil A Halpern, MD

    Education

    BA, Yeshiva University

    MD, Mount Sinai School of Medicine

    , The Mount Sinai Hospital

    , University Health Center of Pittsburgh

    Awards

    2003

    Physician's Recognition Award

    American Medical Association

    2001

    Top Doctors New York Metro Area

    Castle Connolly Medical, Ltd.

    2000

    Physician's Recognition Award

    American Medical Association

    1998

    Certificate of Special Achievement

    Department of Veterans Affairs Medical Center, Bronx, NY

    1997

    Physician's Recognition Award

    American Medical Association

    1993

    Physician's Recognition Award

    American Medical Association

    1993

    Certificate of Appreciation

    Department of Veterans Affairs Medical Center, Bronx, NY

    1992

    Fellowship

    American College of Critical Care Medicine (FCCM)

    1991

    Fellowship

    American College of Angiology (FACA)

    1990

    Physician's Recognition Award

    American Medical Association

    1990

    Certificate of Appreciation

    Department of Veterans Affairs Medical Center, Bronx, NY

    1990

    Fellowship

    American College of Chest Physicians (FCCP)

    1990

    Fellowship

    American College of Physicians (FACP)

    1988

    Special Achievement Award

    Department of Veterans Affairs Medical Center, Bronx, NY

    1986

    Who's Who in the East

    Marquis Who's Who New Providence, NJ

    1986

    Who's Who in the East

    Marquis Who's Who, New Providence, NJ

    1977

    Cum Laude

    Yeshiva University

    1977

    Who's Who Among Students in American Colleges and Universities

    Marquis Who's Who, New Providence, NJ

    Research

    A double blind, placebo controlled study of E5564, A Lipid A Antagonist administered by twice daily intravenous infusions in patients with severe sepsis

    A multi-center randomized, double blind, parallel group-placebo controlled trial on efficacy and safety of activated Recombinant Factor VII (rFVIIa/NovoSeven ) in the treatment of bleeding in patients following hematopoietic stem cell transplantation

    A Safety evaluation of Xigris (Drotecogin alfa activated) in Hematopoietic Stem Cell Transplant Patients with Severe Sepsis

    Industry Relationships